Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (3y) (2017 - 2022)
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (3y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 46.88% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -42.15% |
| Dec 31, 2021 | 37.36% |
| Dec 31, 2020 | -27.85% |
| Sep 30, 2020 | 7.73% |
| Jun 30, 2020 | -27.06% |
| Mar 31, 2020 | 126.06% |
| Dec 31, 2019 | 98.27% |
| Sep 30, 2019 | 157.60% |
| Jun 30, 2019 | 36.05% |
| Mar 31, 2019 | -14.90% |
| Dec 31, 2018 | -43.97% |
| Sep 30, 2018 | 128.65% |
| Jun 30, 2018 | -343.40% |
| Mar 31, 2018 | 802.55% |
| Sep 30, 2017 | -6.98% |